CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Advantages of Using Monoclonal Antibodies

Advantages of Using Monoclonal...

A Brief Overview Of Green Biotechnology Tools And Applications

A Brief Overview Of Green...

Key Advantages of Agtech in Farming

Key Advantages of Agtech in Farming

Nanotechnologys Impact on Environment: What to Know

Nanotechnologys Impact on...

How Automation in Pharmaceutical is Giving a New Direction to Drug Development

How Automation in Pharmaceutical is...

Ways Health Economics and Outcomes Research can Improve Decision Making Process

Ways Health Economics and Outcomes...

Top Agtech Industry Trends to Keep an Eye on

Top Agtech Industry Trends to Keep an...

Strategies to Mitigate Life Sciences Supply Chain Challenges

Strategies to Mitigate Life Sciences...

Advantages of Using Monoclonal Antibodies

Advantages of Using Monoclonal...

A Brief Overview Of Green Biotechnology Tools And Applications

A Brief Overview Of Green...

Key Advantages of Agtech in Farming

Key Advantages of Agtech in Farming

Nanotechnologys Impact on Environment: What to Know

Nanotechnologys Impact on...

How Automation in Pharmaceutical is Giving a New Direction to Drug Development

How Automation in Pharmaceutical is...

Ways Health Economics and Outcomes Research can Improve Decision Making Process

Ways Health Economics and Outcomes...

Top Agtech Industry Trends to Keep an Eye on

Top Agtech Industry Trends to Keep an...

Strategies to Mitigate Life Sciences Supply Chain Challenges

Strategies to Mitigate Life Sciences...

What are the Roadblocks to Digitalization of Biopharmaceutical Industry?

Jeremy Williams, Life Science Review | Sunday, January 24, 2021
Tweet

The biopharmaceutical industry believes that digitalization will help the companies to achieve their strategic imperatives.


Fremont, CA: The large-scale adoption of digital capabilities is lagging, but executives see the potential value of digitalization throughout R&D. Meanwhile, a significant risk aversion to large-scale adoption of digitalization, particularly among the largest companies, is witnessed. Also, digital tools and platforms are becoming more integral in how do the companies collaborate, analyze, and manage data as well as enhance the patient experience.


In a report, the executives stated that they are experiencing opportunities for these digital capabilities to achieve real, measurable value in the organization. The majority of the respondents says that using real world data throughout R&D will improve the decision-making, and some believe that the ability to manage data in a better way across the enterprise may deliver measurable business value.


Most of this potential value lies ahead on the basis of the current level of digital adoption. A few respondents said that they had gained their desired state of digitalization, which is not very surprising because it requires significant investment, the right talent, and generally involves major organizational change.


These barriers then add to the risk aversion, which was noted as one of the most substantial barriers to adoption, especially in more prominent organizations.


 


Here are three roadblocks to digitalization.


• R&D functions are often going it alone- Digitalization is being implemented in silos and is being driven by individual R&D functions. Most of the executives say that digitalization is happening in silos inside their organizations, rather than across functions, throughout R&D, or the entire enterprise.


• Lots of pilots, but few successes at scale- Companies are adopting a cautious and incremental approach to digitalization, with many digital pilots, proofs of concept, and minimum viable products. Together these amount to sizeable investments in digital transformation, but this focus on special use cases rather than the broad relevance, with repeatability and extensibility, means that companies are not able to understand the payoff of digitalization at scale.


• Metrics are needed to measure impact and justify the investment- According to the executives, they struggle to measure the success of digitalization, and without clear metrics, it isn't easy to assess the success of previous investments and justify the potential impact of new investments in emerging technologies. Being able to demonstrate and quantify the value of an initiative is essential, especially when technology adoption means disrupting a currently functioning process.


See also: Top Biotech Solution Companies


Weekly Brief

loading
Towards a New World Order
> <
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Qualities to Consider when Choosing Life Sciences Business Consultants for Your Firm

How Biotech Startups can Mitigate Risks in Order to Grow Sustainably

Cellf BIO's BioShincter to Undergo Phase 1 Trail to Test Fecal Incontinence Treatment

Fulcrum Therapeutics Announces CEO Transition

An Overview of Wholesalers' Roles in Complex Supply Chains

Veeva Opening Up Integration Module for Future Opportunities and Applications

Veeva Systems To Accelerate the CRM of Life Science Businesses

The Role of Technology in Advancing Clinical Trials

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/what-are-the-roadblocks-to-digitalization-of-biopharmaceutical-industry-nwid-73.html